Schmid John P.

CIK 000147891613 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001478916

Recent Transactions

50 trades

Purchase
BlossomHill Therapeutics, Inc.$BLSM
Common Stock
2026-08-10$16.00/sh+6,000→ 6,000 total
Exercise/Conversion
ANAPTYSBIO, INC$ANAB
Common Stock
2026-06-15+6,030→ 37,652 total
Exercise/Conversion
First Tracks Biotherapeutics, Inc.$TRAX
Common Stock
2026-06-15+6,030→ 37,652 total
Exercise/Conversion
First Tracks Biotherapeutics, Inc.$TRAX
Restricted Stock Unit
2026-06-15−6,030→ 0 total
Exercise/Conversion
ANAPTYSBIO, INC$ANAB
Restricted Stock Unit
2026-06-15−6,030→ 0 total
Award
Design Therapeutics, Inc.$DSGN
Stock Option (right to buy)
2026-06-09+30,000→ 30,000 total
Award
First Tracks Biotherapeutics, Inc.$TRAX
Stock Option (right to buy)
2026-05-12+7,000→ 7,000 total
Award
First Tracks Biotherapeutics, Inc.$TRAX
Stock Option (right to buy)
2026-05-12+42,000→ 42,000 total
Award
First Tracks Biotherapeutics, Inc.$TRAX
Restricted Stock Unit
2026-05-12+15,000→ 15,000 total
Award
First Tracks Biotherapeutics, Inc.$TRAX
Restricted Stock Unit
2026-05-12+2,500→ 2,500 total
Award
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2026-04-20+10,600→ 10,600 total
Disposition to Issuer
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2026-04-20−6,000→ 6,000 total
Disposition to Issuer
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2026-04-20−6,000→ 6,000 total
Disposition to Issuer
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2026-04-20−16,510→ 16,510 total
Award
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2026-04-20+5,500→ 5,500 total
Disposition to Issuer
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2026-04-20−10,600→ 10,600 total
Disposition to Issuer
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2026-04-20−16,510→ 16,510 total
Award
First Tracks Biotherapeutics, Inc.$TRAX
Stock Option (right to buy)
2026-04-20+15,000→ 15,000 total
Award
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2026-04-20+9,200→ 9,200 total
Award
First Tracks Biotherapeutics, Inc.$TRAX
Stock Option (right to buy)
2026-04-20+6,000→ 6,000 total
Disposition to Issuer
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2026-04-20−15,000→ 15,000 total
Disposition to Issuer
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2026-04-20−9,200→ 9,200 total
Award
First Tracks Biotherapeutics, Inc.$TRAX
Stock Option (right to buy)
2026-04-20+11,000→ 11,000 total
Award
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2026-04-20+15,000→ 15,000 total
Disposition to Issuer
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2026-04-20−11,000→ 11,000 total
Award
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2026-04-20+6,000→ 6,000 total
Disposition to Issuer
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2026-04-20−11,000→ 11,000 total
Award
First Tracks Biotherapeutics, Inc.$TRAX
Stock Option (right to buy)
2026-04-20+10,600→ 10,600 total
Award
First Tracks Biotherapeutics, Inc.$TRAX
Restricted Stock Unit
2026-04-20+6,030→ 6,030 total
Disposition to Issuer
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2026-04-20−5,500→ 5,500 total
Award
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2026-04-20+11,000→ 11,000 total
Award
First Tracks Biotherapeutics, Inc.$TRAX
Restricted Stock Unit
2026-04-20+4,000→ 4,000 total
Award
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2026-04-20+11,000→ 11,000 total
Award
First Tracks Biotherapeutics, Inc.$TRAX
Stock Option (right to buy)
2026-04-20+5,500→ 5,500 total
Award
First Tracks Biotherapeutics, Inc.$TRAX
Stock Option (right to buy)
2026-04-20+16,510→ 16,510 total
Award
First Tracks Biotherapeutics, Inc.$TRAX
Stock Option (right to buy)
2026-04-20+16,510→ 16,510 total
Award
First Tracks Biotherapeutics, Inc.$TRAX
Stock Option (right to buy)
2026-04-20+9,200→ 9,200 total
Award
First Tracks Biotherapeutics, Inc.$TRAX
Stock Option (right to buy)
2026-04-20+11,000→ 11,000 total
Award
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2026-04-20+16,510→ 16,510 total
Award
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2026-04-20+16,510→ 16,510 total
Award
First Tracks Biotherapeutics, Inc.$TRAX
Stock Option (right to buy)
2026-04-20+6,000→ 6,000 total
Award
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2026-04-20+6,000→ 6,000 total
Sale
ANAPTYSBIO, INC$ANAB
Common Stock
2026-03-30$56.70/sh−7,527→ 32,144 total
Sale
ANAPTYSBIO, INC$ANAB
Common Stock
2026-03-30$57.40/sh−522→ 31,622 total
Sale
ANAPTYSBIO, INC$ANAB
Common Stock
2026-03-30$55.71/sh−12,596→ 39,671 total
Award
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2026-01-06+5,500→ 5,500 total
Award
ANAPTYSBIO, INC$ANAB
Restricted Stock Unit
2026-01-06+4,000→ 4,000 total
Other
ANAPTYSBIO, INC$ANAB
Common Stock
2025-12-23$51.00/sh−11,068→ 0 total
Exercise/Conversion
BridgeBio Oncology Therapeutics, Inc.$BBOT
Class B ordinary shares
2025-08-11−30,000→ 0 total
Exercise/Conversion
BridgeBio Oncology Therapeutics, Inc.$BBOT
Common Stock
2025-08-11+30,000→ 30,000 total

Companies

Recent Filings

Address

C/O BLOSSOMHILL THERAPEUTICS, INC. 10255 SCIENCE CENTER DRIVE, SUITE 200

SAN DIEGO, CA, 92121

View on SEC.gov